Néoplasie

Fr | De

Feedback | Impressum | Sitemap

Aucun choix d'articles!

Panier

Vous êtes ici: Recherche de documentation spécialisée » Estomac / intestins » Néoplasie

08. Septembre 2026

Dépistage / diagnostic

Recherche de documentation spécialisée

MII (maladie de Crohn/colite)

Troubles fonctionnels

Écriture:

Page 1 de 12232


	Articles 1 - 20 / 244638

	Stomach cancer burden among older adults in aged and super-aged societies, 1990-2023: a global analysis: A short informative title: Elderly Stomach Cancer Burden in Aged and Super-Aged Countries, 1990-2023. Ageing Res Rev Xu C, Wang Y, Liang Q, Lv W, Chen B, Qiu W. PMID: 42705484 [PubMed - as supplied by publisher]
	Chemotherapy with or without pembrolizumab followed by maintenance pembrolizumab with or without olaparib as first-line treatment of patients with advanced BRCA non-mutated epithelial ovarian cancer (ENGOT-OV43/GOG-3036/KEYLYNK-001): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Oncol Vergote I, Cibula D, Powell M, Laenen A, Nieuwenhuysen EV, Topuz S, González-Martín A, Fujiwara K, Safina S, Bagaméri A, Oliver M, Lee JY, Salutari V, Korach J, Lu CH, M, Vulsteke C, Colombo N, Sehouli J, Klat J, Ruiz EY, Gilbert L, Pautier P, Pardo B, Kridelka F, Wei J, Toker S, Yamada K, Coleman RL, ENGOT-OV43/GOG-3036/KEYLYNK-001 investigators. PMID: 42705254 [PubMed - as supplied by publisher]
	[Colorectal Cancer]. Dtsch Med Wochenschr Pox C. PMID: 42705241 [PubMed - indexed for MEDLINE]
	[Neuroendocrine Tumors of the Gastrointestinal Tract]. Dtsch Med Wochenschr Rinke A, Eilsberger F, Stathopoulos P. PMID: 42705240 [PubMed - indexed for MEDLINE]
	Anilino-1,4-naphthoquinone derivatives exhibit antiproliferative, anti-inflammatory, and pro-apoptotic activities in LPS-stimulated SW480 colorectal cancer cells: In vitro and in silico studies. Biomed Pharmacother Punpai S, Mahalapbutr P, Taweechat P, Leechaisit R, Choowongkomon K, Pingaew R, Tanechpongtamb W. PMID: 42705103 [PubMed - as supplied by publisher]
	Long-term trajectories of health-related quality of life after curative surgery in early-stage esophageal cancer: A prospective cohort study in Korea. Eur J Surg Oncol You S, Lee G, Shim YM, Park SY, Cho JH, Choi YS, Lee J, Jeon YJ, Kang D, Batirel HF, Kim HK, Cho J. PMID: 42705092 [PubMed - as supplied by publisher]
	Predicting the risk of dehydration and readmission among rectal cancer patients with ileostomy: a multicenter observational study. Updates Surg Ferrara F, Rizzo G, Parini D, Cassini D, Sanità MD, Alessi F, Bondurri A, MISSTO Snapshot Study Collaborative. PMID: 42704598 [PubMed - as supplied by publisher]
	Evidence Gap in Managing Lateral Pelvic Lymph Nodes in Rectal Cancer: a Systematic Review of Radiation Boost Strategies. J Gastrointest Cancer Pinar SA, Wong TN, Mitchell T, Kong CY. PMID: 42704578 [PubMed - indexed for MEDLINE]
	Staying minimally invasive: robotic versus laparoscopic colorectal cancer surgery in a propensity-weighted Italian multicentre cohort. J Robot Surg Giordano A, Marano L, Lamacchia G, Andreuccetti J, Brillantino A, Farina M, Mineccia M, Ranucci MC, Barone M, Mastronardi M, Cillara N, ATOCCS Collaborative Group. PMID: 42704554 [PubMed - indexed for MEDLINE]
	Does age have an impact on surgical and oncologic outcomes after curative resection for gastric cancer: a ten-year single-centre retrospective study. Radiol Oncol Horvat M, Potrc S, Arslani N. PMID: 42704037 [PubMed - indexed for MEDLINE]
	The role of particle therapy in the treatment of locally recurrent rectal cancer: a systematic review. Radiol Oncol Perpar A, Georg P, Ermenc AS. PMID: 42704036 [PubMed - indexed for MEDLINE]
	Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: a single-institution experience. Radiol Oncol Pilko G, Petric R. PMID: 42704034 [PubMed - indexed for MEDLINE]
	Metabolomic Profiling of Plasma Bile Acids in Resectable Gastric Cancer. Chirurgia (Bucur) Ursu , Ciocan RA, Ursu CP, Moldovan RC, Zaharie F, Spârchez Z, Moisoiu T, B, Pop RS, Bodea CI, Iuga CA, Gherman CD, Hajjar NA. PMID: 42703977 [PubMed - indexed for MEDLINE]
	Prediction of histological response by PET-CT after 2 weeks of neoadjuvant chemo-radiotherapy for rectal cancer: a prospective clinical trial. J Gastrointest Oncol Reinhorn D, Kundel Y, Gordon N, Prus J, Morgenstern S, Wasserberg N, Groshar D, Bernstine H, Brenner B. PMID: 42703514 [PubMed]
	De-escalated total neoadjuvant therapy for the non-operative management of rectal cancer: Results of the NOM-3/TNT prospective cohort study. Clin Transl Radiat Oncol Skrzypiec B, Paciorek K, Pietrzak L, , Kaminski MF, Wro, Ho, Kapa, Ta, Olesi, Bujko K. PMID: 42703503 [PubMed]
	Trajectory identification of high-risk subgroups after colorectal cancer surgery in patients with minimal residual disease: a single-center longitudinal study. J Gastrointest Oncol Zhang Y, Liang L, Zhou R, Wu S, Zhou Y, Luo J, Zeng Y, Xu N, Wen Z. PMID: 42703488 [PubMed]
	Global, regional, and national burden of colorectal cancer attributable to modifiable risk factors, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. J Gastrointest Oncol Yu M, Lu YP. PMID: 42703476 [PubMed]
	Development of a postoperative risk scoring tool for elderly patients with early gastric cancer: an exploratory prognostic score derivation study. J Gastrointest Oncol Yoo J, Chung B, Kim J, Jeong SA, Min SH, Gong CS, Lee IS, Kim BS, Yoo MW, Yook JH, Kim S, Ko CS. PMID: 42703472 [PubMed]
	Prognostic impact of mucinous adenocarcinoma after curative surgery for stage I-III colorectal cancer: a large population-based cohort study. J Gastrointest Oncol Li J, Zeng T, Xie X, Li D, Yan K, Zhu H. PMID: 42703468 [PubMed]
	Second-line raltitrexed plus irinotecan (SALIRI) with bevacizumab, cetuximab, or alone for metastatic colorectal cancer: a prospective multicenter cohort-based secondary analysis of the SALLY trial. J Gastrointest Oncol Kou F, Wang X, Li J, Wang Z, Xu T. PMID: 42703466 [PubMed]

Articles 1 - 20 / 244638

Page 1 de 12232



		Intervalle de temps demandé

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy \| Publicité